Decibel Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch DBTX and buy or sell other stocks, ETFs, and their options commission-free!About DBTX
Decibel Therapeutics is a developer of hearing disorder therapeutics intended to protect, repair and restore hearing. The company's therapeutics have provided insights into the link between hearing dysfunction and inner ear pathology and it has capabilities to encompass animal models, drug delivery to the inner ear, imaging, inner ear PK/PD modeling and measurement, bioinformatics, genetics and target identification, enabling patients to experience hearing loss therapies with different forms of hearing disorders for their recovery.
CEOLaurence E. Reid, PhD
CEOLaurence E. Reid, PhD
Employees—
Employees—
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2015
Founded2015
Employees—
Employees—
DBTX Key Statistics
Market cap123.37M
Market cap123.37M
Price-Earnings ratio-1.94
Price-Earnings ratio-1.94
Dividend yield—
Dividend yield—
Average volume267.14K
Average volume267.14K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.40
52 Week high$5.40
52 Week low$1.61
52 Week low$1.61
People also own
Based on the portfolios of people who own DBTX. This list is generated using Robinhood data, and it’s not a recommendation.